Health
Common heart drugs are safe for patients hospitalized with COVID-19 – News-Medical.net
Heart patients hospitalized with COVID-19 can safely continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), according to the BRACE CORONA trial presented in a Hot Line session today at ESC Congress 2020.
Reviewed by Emily Henderson, B.Sc.Sep 1 2020
Heart patients hospitalized with COVID-19 can safely continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), according to the BRACE CORONA trial presented in a Hot Line session today at ESC Congress 2020.
ACE inhibitors and ARBs are commonly taken by heart patients to reduce blood pressure and to treat heart failure. There is conflicting observational evidence about the potential clinical impact of AC…
-
Business23 hours agoForget CBA and buy these high-yield ASX dividend shares
-
Business24 hours agoHere’s a starter portfolio of ASX 200 shares to consider for growth, dividends, and value!
-
Noosa News20 hours agoMan dies after stabbing in inner-city unit
-
Noosa News23 hours agoThe Almond Ashes sees Australia and India mix business and cricket